PTCT Stock Analysis: Buy, Sell, or Hold?
PTCT - PTC Therapeutics, Inc.
$68.12
0.10 (0.15%)
▲
5d:
-10.14%
30d:
-18.24%
90d:
+4.55%
WAIT
LOW Confidence
Analysis Updated: Jul 31, 2026 12:00 AM ET
Earnings: Jul 30, 2026
0d
Smart Money Accumulation
None View Scanner →
Strength: 6.6/10
Get Alerted When PTCT Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: PTCT is down 10.1% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: PTCT is down 10.1% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$138.75
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$86.15
20.9% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: PTCT is currently trading at $68.11, which is considered oversold relative to its 30-day fair value range of $74.57 to $85.22. From a valuation perspective, the stock is trading at a discount (Forward PE: 23.9) compared to its historical average (27.0). Remarkably, the market is currently pricing in an annual earnings decline of 4.0% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, PTCT is in a strong uptrend. Immediate support is located at $64.57, while resistance sits at $80.56.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $96.93 (+42.3%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, PTCT is in a strong uptrend. Immediate support is located at $64.57, while resistance sits at $80.56.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $96.93 (+42.3%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$74.57 -
$85.22
Company Quality Score
57/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
79.5%
Protect Your Profits
Holding PTCT? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (55/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 42.3% below Wall St target ($96.93)
- WARNING: Recommendation downgraded due to -10.1% 5-day decline - wait for stabilization
Trading Range Analysis
30-Day Trading Range
$74.57 -
$85.22
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$64.57
Resistance Level
$80.56
Current Trend
Strong Uptrend
Technical data as of
Aug 3, 2026
Fundamental Context
Forward P/E (Next Year Est.)
23.90
Wall Street Target
$96.93
(+42.3%)
Revenue Growth (YoY)
101.5%
Profit Margin
-3.8%
Valuation Discount vs History
-4.0% cheaper
PE vs Historical
23.9 vs 27.0
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-4.0%
(market-implied from PE analysis)
1-Year Target
$65.39
(-4%)
2-Year Target
$62.77
(-8%)
3-Year Target
$60.26
(-12%)
3-Yr Target (if PE normalizes)
(PE: 24→27)
$68.08
(0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 23.9, Growth: 91.3%)
$229.89
(+238%)
Base:
(SPY PE: 20.7, Growth: 91.3%)
$199.40
(+193%)
Bear:
(PE: 17.6, Growth: 91.3%)
$169.49
(+149%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 23.9 to 27.0
Stabilization Target:
$76.95
(+13.0%)
PE Expansion Potential:
+13.0%
Share & Embed Analysis
Last updated: August 04, 2026 2:30 AM ET
Data refreshes hourly during market hours. Next update: 3:30 AM
Data refreshes hourly during market hours. Next update: 3:30 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is PTCT showing a specific setup today?
Insider Activity (6 Months)
0
Buys
19
Sells
Net
INSIDERS SELLING
Recent Transactions
Matthew B Klein
SELL
2850 shares
2026-04-21
Mark Elliott Boulding
SELL
2265 shares
2026-04-06
Lee Scott Golden
SELL
829 shares
2026-04-02
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ONC
BeiGene, Ltd. |
STRONG BUY
24 analysts |
$416 | 53 HOLD |
|
CRSP
Crispr Therapeutics AG |
BUY
28 analysts |
$87 | 53 HOLD |
|
INSM
Insmed Inc |
STRONG BUY
21 analysts |
$196 | 47 HOLD |
|
CYTK
Cytokinetics Inc |
STRONG BUY
21 analysts |
$108 | 60 HOLD |
|
CRNX
Crinetics Pharmaceutical… |
STRONG BUY
17 analysts |
$86 | 47 HOLD |
Advanced PTCT Option Strategies
Professional options setups generated by AI based on today's PTCT price and gamma walls.
